Business Context and Reporting Period
This Form 8-K Current Report was filed by Marchex, Inc. on February 28, 2006. The filing discloses the establishment of Rule 10b5-1 trading plans by the company's directors, officers, and certain employees to facilitate pre-determined sales of Marchex common stock for asset diversification and liquidity purposes.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on insider trading plan disclosures and contains no financial performance data.
Material Changes
The material event reported is the adoption of Rule 10b5-1 trading plans by six key insiders on February 28, 2006. These plans authorize the sale of shares over specific future periods, with sales commencing no earlier than six months to one year from the filing date.
Guidance, Outlook, and Management Commentary
Management commentary indicates that these plans are intended to allow insiders to diversify holdings and minimize market impact by spreading sales over time. The plans were adopted in accordance with the Marchex Code of Conduct. No financial guidance or outlook regarding company operations is provided in this filing.
Insider Trading Plan Details
- Russell C. Horowitz (Chairman & CEO): Up to 1,560,000 shares over 24 months, commencing Feb 28, 2007. Represents ~16% of his holdings and ~4% of total outstanding common stock.
- Michael Arends (CFO): Up to 116,000 shares over 24 months, commencing Feb 28, 2007. Represents ~20% of his holdings.
- Ethan Caldwell (General Counsel): Up to 150,000 shares over 24 months, commencing Feb 28, 2007. Represents ~18% of his holdings.
- John Keister (President & COO): Up to 528,000 shares over 24 months, commencing Feb 28, 2007. Represents ~20% of his holdings and ~1% of total outstanding common stock.
- Dennis Cline (Director): Up to 16,500 shares over 9 months, commencing Aug 28, 2006. Represents ~11% of his holdings.
- Rick Thompson (Director): Up to 200,000 shares over 9 months, commencing Aug 28, 2006. Represents ~16% of his holdings.
Important Facts for Investor Verification
- Verify the total number of outstanding shares to confirm the percentage impact of the proposed sales on the total float.
- Monitor future filings to track actual execution of these sales plans against the disclosed maximums.
- Note that sales for the CEO, CFO, General Counsel, and President are delayed until February 2007, while sales for two directors may begin in August 2006.
- Confirm that no material non-public information was possessed by insiders at the time these plans were established.